Document is current
Any future updates will be listed below
-
Authors
Cheng, Hung-Wei
Mörbe, Urs https://orcid.org/0000-0001-8747-437X
Lütge, Mechthild https://orcid.org/0000-0001-9011-5319
Engetschwiler, Céline
Onder, Lucas
Novkovic, Mario https://orcid.org/0000-0001-7654-5777
Gil-Cruz, Cristina
Perez-Shibayama, Christian
Hehlgans, Thomas
Scandella, Elke
Ludewig, Burkhard https://orcid.org/0000-0002-7685-573X
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (182583, 159188, 151370)
Deutsche Forschungsgemeinschaft (HE3116/9-1)
- License Information
-
More Information
Article History
Received: 21 July 2021
Accepted: 21 March 2022
First Online: 19 April 2022
Competing interests
: B.L., L.O., H.-W.C., C.G.-C., and C.P.-S. are cofounders and shareholders of Stromal Therapeutics. H.-W.C. is a part-time employee of Stromal Therapeutics. The remaining authors declare no competing interests.
